Biotech

All Articles

Takeda takes $140M loss on neglected epilepsy drug, touts FDA run

.Our company already understand that Takeda is wishing to locate a path to the FDA for epilepsy medi...

VBI Injections files for bankruptcy, finds resource sale

.Immunology biotech VBI Vaccines is actually veering dangerously near to the climax, with strategies...

Celldex anti-cKIT antitoxin minimize hives in another period 2 study

.It is actually not easy to muscle mass in on a room as reasonable as immunology, but Celldex Rehabs...

Boehringer provides to $1.3 B for checkpoint inhibitor biotech

.Boehringer Ingelheim is offering up to $1.3 billion for Nerio Therapies and also a preclinical invu...

Ventyx's last resort for inflammatory med ends in Crohn's failing

.Ventyx Biosciences' Crohn's illness medicine performed certainly not assist people achieve remissio...

Cognition's period 2 radiate records stain Alzheimer's possibility

.Knowledge Therapeutics' period 2 SHINE trial has taken some of the luster off the Alzheimer's healt...

BMS axes bispecific months after filing to operate period 3 trial

.Bristol Myers Squibb has actually possessed a whiplash change of mind on its BCMA bispecific T-cell...

Charles Baum manages Terremoto as chief executive officer

.Charles Baum, M.D., Ph.D., that looked after Mirati Therapies' $ 5.8 billion sale to Bristol Myers ...

Asarina to shut after attempts to companion Tourette's medicine neglect

.After reaching out to more than 200 providers to companion a Tourette syndrome therapy that reveale...

Novartis markers $150M in advance bispecifics deal with Dren Biography

.Novartis has had some rotten luck along with bispecific antibodies previously, but determining by t...